JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB48775

Recombinant Human Ube2L3/UBCH7 protein

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human Ube2L3/UBCH7 protein is a Human Full Length protein, in the 1 to 154 aa range, expressed in Escherichia coli, with >95%, suitable for SDS-PAGE.

View Alternative Names

UBCE7, UBCH7, UBE2L3, Ubiquitin-conjugating enzyme E2 L3, E2 ubiquitin-conjugating enzyme L3, L-UBC, UbcH7, Ubiquitin carrier protein L3, Ubiquitin-conjugating enzyme E2-F1, Ubiquitin-protein ligase L3

1 Images
SDS-PAGE - Recombinant Human Ube2L3/UBCH7 protein (AB48775)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant Human Ube2L3/UBCH7 protein (AB48775)

14% SDS-PAGE gel loaded with ab48775
recombinant human Ube2L3/UBCH7 protein
predicted molecular weight 17.9KDa

Key facts

Purity

>95% SDS-PAGE

Expression system

Escherichia coli

Tags

Tag free

Applications

SDS-PAGE

applications

Biologically active

No

Accession

P68036

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7.4 Constituents: 10% Glycerol (glycerin, glycerine), 1.19% HEPES, 0.87% Sodium chloride, 0.0154% (R*,R*)-1,4-Dimercaptobutan-2,3-diol

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

This product was previously labelled as Ube2L3

Sequence info

[{"sequence":"MAASRRLMKELEEIRKCGMKNFRNIQVDEANLLTWQGLIVPDNPPYDKGAFRIEINFPAEYPFKPPKITFKTKIYHPNIDEKGQVCLPVISAENWKPATKTDQVIQSLIALVNDPQPEHPLRADLAEEYSKDRKKFCKNAEEFTKKYGEKRPVD","proteinLength":"Full Length","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":154,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"P68036","tags":[]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Ube2L3 also known as UBCH7 is an E2 ubiquitin-conjugating enzyme with a molecular weight of approximately 21 kDa. This enzyme participates mechanically in the ubiquitination process where it transfers ubiquitin from an E1 activating enzyme to an E3 ligase mediating protein degradation through the proteasome. Ube2L3 is expressed ubiquitously in various tissues showing higher abundance in the brain heart and skeletal muscle.
Biological function summary

Ube2L3 plays essential roles in protein turnover and cell cycle regulation by functioning within multi-protein complexes. It helps facilitate the attachment of ubiquitin to specific target proteins marking them for degradation. These activities are important for maintaining protein homeostasis and regulation of cell division apoptosis and signal transduction. Ube2L3's role in these biological processes makes it an important component of cellular function and physiology.

Pathways

Ube2L3 is involved in the ubiquitin-proteasome pathway and is also associated with the NF-kB signaling pathway. Its function in these pathways highlights its role in regulating immune responses and inflammatory processes. Interaction with other proteins like E3 ligases including Parkin and Mdm2 shows its involvement in protein quality control and cellular stress responses. Ube2L3's modulation of these pathways is significant for proper cellular responses to environmental cues and stressors.

Ube2L3 associates with conditions like autoimmune diseases and certain cancers. Research links dysfunction in Ube2L3's activity to systemic lupus erythematosus (SLE) where immune regulation is disrupted. Furthermore studies indicate that alterations in its protein interactions particularly with E3 ligases such as Mdm2 might contribute to tumorigenesis by affecting p53 regulation. Understanding these connections helps in elucidating the roles of Ube2L3 in disease mechanisms and may support the development of targeted therapies.

Specifications

Form

Liquid

Additional notes

Ube2L3/UBCH7 was overexpressed in E.coli and purified by using conventional chromatography techniques.

General info

Function

Ubiquitin-conjugating enzyme E2 that specifically acts with HECT-type and RBR family E3 ubiquitin-protein ligases. Does not function with most RING-containing E3 ubiquitin-protein ligases because it lacks intrinsic E3-independent reactivity with lysine; in contrast, it has activity with the RBR family E3 enzymes, such as PRKN, RNF31 and ARIH1, that function like RING-HECT hybrids. Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. Mediates ubiquitination by the CUL9-RBX1 complex (PubMed : 38605244). In vitro catalyzes 'Lys-11'-linked polyubiquitination. Involved in the selective degradation of short-lived and abnormal proteins. Down-regulated during the S-phase it is involved in progression through the cell cycle. Regulates nuclear hormone receptors transcriptional activity. May play a role in myelopoiesis.

Sequence similarities

Belongs to the ubiquitin-conjugating enzyme family.

Post-translational modifications

Ubiquitinated. The alteration of UBE2L3 protein levels during the S-phase of the cell cycle is due to ubiquitin-dependent proteasomal degradation. Autoubiquitinated in vitro (PubMed:22496338).

Subcellular localisation

Nucleus

Product protocols

Target data

Ubiquitin-conjugating enzyme E2 that specifically acts with HECT-type and RBR family E3 ubiquitin-protein ligases. Does not function with most RING-containing E3 ubiquitin-protein ligases because it lacks intrinsic E3-independent reactivity with lysine; in contrast, it has activity with the RBR family E3 enzymes, such as PRKN, RNF31 and ARIH1, that function like RING-HECT hybrids. Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. Mediates ubiquitination by the CUL9-RBX1 complex (PubMed : 38605244). In vitro catalyzes 'Lys-11'-linked polyubiquitination. Involved in the selective degradation of short-lived and abnormal proteins. Down-regulated during the S-phase it is involved in progression through the cell cycle. Regulates nuclear hormone receptors transcriptional activity. May play a role in myelopoiesis.
See full target information UBE2L3

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com